Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind vehicle-controlled study of Cequa for dry eye disease
CTR20201772Phase 3Active
- Sponsor
- Sun Pharma
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciclosporin in dry eye syndrome (DED), sponsored by Sun Pharma. Started Sep 2020; status: active.
02
Drugs
ciclosporin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20201772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201772.